MedTrace Logo

Immuno-molecular Approaches for Non-invasive Diagnosis of Prostate Cancer

NCT04702633 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 127

Last updated 2025-11-20

No results posted yet for this study

Summary

The purpose of this study is to isolate and characterize tumor cells non-invasively from biological samples in patients with prostate cancer and demonstrate the ability to identify the presence and number of tumor cells before prostate biopsy.

Conditions

Interventions

OTHER

Results obtained by biopsy and MRI results.

Results obtained by biopsy and MRI results.

OTHER

Clinical data

Clinical data

Sponsors & Collaborators

  • Rarecells Diagnostics SAS

    collaborator INDUSTRY

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Patrizia PATERLINI-BRECHOT, MD, PhD · INSERM and Rarecells Diagnostics

Eligibility

Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-19
Primary Completion
2022-04-30
Completion
2022-05-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04702633 on ClinicalTrials.gov